Zobrazeno 1 - 10
of 68
pro vyhledávání: '"Paul A Chervenick"'
Autor:
J. Raychaudhuri, Ling Zhang, Lia Perez, Ernesto Ayala, Rachid Baz, Salvador Bruno, Jennifer L. Cultrera, Eduardo M. Sotomayor, Lubomir Sokol, Jane Jijun Liu, Teresa Field, Paul A. Chervenick, Jose L. Ochoa-Bayona, Celeste M. Bello, Mohamed A. Kharfan-Dabaja
Publikováno v:
Leukemia Research. 35:1571-1577
Plasmablastic lymphoma (PBL) is a rare aggressive B-cell lymphoproliferative disorder. HIV-negative PBL has not been extensively reported. Nine HIV-negative PBL patients evaluated at Moffitt Cancer Center were studied. Eight patients had extranodal d
Publikováno v:
Asian cardiovascularthoracic annals. 25(1)
Autor:
Julio C. Chavez, Mohamed A. Kharfan-Dabaja, Samir Dalia, Lubomir Sokol, Celeste M. Bello, Eduardo M. Sotomayor, Joseph Clara, Luis Miguel Juarez Salcedo, Paul A. Chervenick, Bijal D. Shah
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 16:S106-S107
Autor:
Jose D Sandoval-Sus, Paola Parra, Celeste M. Bello, Eduardo M. Sotomayor, Paul A. Chervenick, Bijal D. Shah, Lubomir Sokol, Jeffrey E. Lancet, Ernesto Ayala, Julio C. Chavez, Frederick L. Locke, Mohamed A. Kharfan-Dabaja
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 16:S115-S116
Autor:
Bijal D. Shah, Celeste M. Bello, Paul A. Chervenick, Rami S. Komrokji, Samir Dalia, Julio C. Chavez, Mohamed A. Kharfan-Dabaja, Joseph Clara, Eduardo M. Sotomayor, Lubomir Sokol, Emilie Wang
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 17:S376
Autor:
Bijal D. Shah, Bryan J Little, Samir Dalia, Lubomir Sokol, Ji-Hyun Lee, Julio C. Chavez, Kate Fisher, Celeste M. Bello, Paul A. Chervenick, Eduardo M. Sotomayor
Publikováno v:
Annals of hematology. 93(8)
Serum albumin (SA) has been shown to be a prognostic marker in many hematological malignancies and in diffuse large B-cell lymphoma (DLBCL) prior to chemo-immunotherapy. SA may be a surrogate for age, comorbid status, and disease severity. Here, we a
Autor:
Jose D Sandoval-Sus, Lubomir Sokol, Eduardo M. Sotomayor, Andrew T. Kuykendall, Samir Dalia, Bijal D. Shah, Julio C. Chavez, Mohamed A. Kharfan-Dabaja, Chetasi Talati, Celeste M. Bello, Ernesto Ayala, Frederick L. Locke, Jori Kaplan, Farhad Khimani, Paul A. Chervenick
Publikováno v:
Blood. 128:1870-1870
Background: MYC positive double hit lymphomas (DHL) (presence of c-myc and BCL2 or BCL6 rearrangements by florescence in situ hybridization (FISH) analysis) and double protein expressor lymphomas (DEL) (protein expression by immunohistochemistry (IHC
Autor:
Andrew T. Kuykendall, Bijal D. Shah, Samir Dalia, Eduardo M. Sotomayor, Frederick L. Locke, Celeste M. Bello, Chetasi Talati, Ernesto Ayala, Paul A. Chervenick, Jose D Sandoval-Sus, Jori Kaplan, Julio C. Chavez, Mohamed A. Kharfan-Dabaja, Lubomir Sokol
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 16:S99
Autor:
Eduardo M. Sotomayor, Celeste M. Bello, Jose Sandoval-Sus, Paul A. Chervenick, Samantha Shams, Patrick T. Griffin, Mohamed A. Kharfan-Dabaja, Bijal D. Shah, Ernesto Ayala, Luis Miguel Juárez Salcedo, Lubomir Sokol, Julio C. Chavez
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 16:S116
Autor:
Eduardo M. Sotomayor, Celeste M. Bello, Jeffrey E. Lancet, Chetasi Talati, Javier Pinilla-Ibarz, Jose Sandoval-Sus, Bijal D. Shah, Frederick L. Locke, Paul A. Chervenick, Samir Dalia, Julio C. Chavez, Lubomir Sokol, Mohamed A. Kharfan-Dabaja
Publikováno v:
Journal of Clinical Oncology. 34:7534-7534
7534Background: Genetic abnormalities in chronic lymphocytic leukemia (CLL) have prognostic impact. The presence of trisomy 12 (T12) and normal karyotype (NK), and 13q deletion (del13q) are associated with an intermediate and good risk profile in CLL